TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - AMGEN TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - AMGEN Share Price
Certificat
DE000SD4L9T4
| Real-time Boerse Frankfurt Warrants 05:47:22 24/06/2024 pm IST | ||
| 11.34 EUR | -1.22% |
|
| Current month | +5.13% | ||
| 1 month | -3.20% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 11.34 | -1.22% |
| 21/24/21 | 11.48 | +0.97% |
| 20/24/20 | 11.37 | +3.65% |
| 19/24/19 | 10.97 | -0.36% |
| 18/24/18 | 11.01 | +2.04% |
Real-time Boerse Frankfurt Warrants
Last update June 24, 2024 at 05:47 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SD4L9T |
| ISIN | DE000SD4L9T4 |
| Date issued | 12/03/2021 |
| Strike | 189.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.32 € |
|---|---|
| Lowest since issue | 3.25 € |
| Spread | 0.12 € |
| Spread % | 1.05% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
308.2
USD
Average target price
316.4
USD
Spread / Average Target
+2.69%
- Stock Market
- Certificates
- Certificat
